Anistreplase
Anistreplase
Anistreplase (pronounced: an-is-trep-lase) is a thrombolytic agent used in the treatment of acute myocardial infarction (heart attack) and other conditions related to blood clotting.
Etymology
The term 'Anistreplase' is derived from the words 'anisoylated' and 'streptokinase'. 'Anisoylated' refers to the process of attaching an anisoyl group to another molecule, in this case, streptokinase. 'Streptokinase' is an enzyme produced by certain strains of streptococci bacteria, which has the ability to dissolve blood clots.
Usage
Anistreplase is used as a thrombolytic agent, which means it helps to dissolve blood clots. It is often used in the treatment of acute myocardial infarction, also known as a heart attack. It works by activating the plasminogen in the body, which then breaks down the fibrin in blood clots.
Related Terms
- Thrombolytic: A type of drug that dissolves blood clots.
- Acute myocardial infarction: A medical term for a heart attack.
- Streptococci: A type of bacteria that can cause a variety of infections.
- Plasminogen: A protein in the blood that is converted into plasmin, an enzyme that dissolves blood clots.
- Fibrin: A protein involved in the clotting of blood.
See Also
External links
- Medical encyclopedia article on Anistreplase
- Wikipedia's article - Anistreplase
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski